Regulatory Commentshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments.aspxCopyright 2008en-usFri, 30 Jul 2010 23:38:59 GMT12010: PDA Comments on EU GMP Annex 2: Manufacture of Biological Medicinal Substances and Products for Human Usehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2010-PDA-Comments-on-EU-GMP-Annex-2-Manufacture-of-Biological-Medicinal-Substances-and-Products-.aspxPDA is pleased to provide comments on the latest revision of the EU GMP Annex 2.Mon, 26 Jul 2010 12:39:42 GMT2010: PDA Comments to the EU Guidelines to GMP, Part 1, Medicinal Products for Human and Veterinary Use, Chapter 2, Personnelhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2010-PDA-Comments-to-the-EU-Guidelines-to-GMP-Part-1-Medicinal-Products-for-Human-and-Veterinary.aspxPDA is pleased to provide comments on the revised Chapter 2 of the EU GMP, originating November 18, 2009.Wed, 02 Jun 2010 09:27:43 GMT2010: PDA Comments to the EU Guidelines to GMP Part I, Medicinal Products for Human and Veterinary Use, Chapter 1, Quality Management Systemhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2010-PDA-Comments-to-the-EU-Guidelines-to-GMP-Part-I-Medicinal-Products-for-Human-and-Veterinary-.aspxPDA is pleased to provide comments on the revised Chapter 1 of the EU GMP, originating from November 18, 2009.Wed, 02 Jun 2010 09:24:26 GMT2009: PDA Comments to Concept Paper on the Revision of the EU Guideline on GDPhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2009-PDA-Comments-to-Concept-Paper-on-the-Revision-of-the-EU-Guideline-on-GDP.aspxPDA is pleased to offer comments on the concept paper pertaining to the revision of the European Guideline on Good Distribution Practices (GDP)Wed, 05 May 2010 12:29:18 GMTPDA Comments on the Concept Paper for Implementation of ICHQ10http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-the-Concept-Paper-for-Implementation-of-ICHQ10.aspxPDA is pleased to provide comments on the Concept Paper for the Implementation of ICH Q10 in the European GMP Guide.Wed, 05 May 2010 12:19:09 GMTPDA Responds to FDA's Request for Comments on the Transparency Task Forcehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-FDAs-Request-for-Comments-on-the-Transparency-Task-Force.aspxPDA is pleased to respond to the FDA's request for comments on the Transparency Task Force.Thu, 15 Apr 2010 12:32:27 GMT2010: PDA Comments on "Explanatory Notes for Pharmaceutical Manufacturers on the Preparation of a Site Master File and Content of a Site Master Filehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2010-PDA-Comments-on-Explanatory-Notes-for-Pharmaceutical-Manufacturers-on-the-Preparation-of-a-S.aspxPDA is pleased to offer comments on the Note for Guidance on Explanatory Notes for Pharmaceutical Manufacturers on the Preparation of a Site Master File and Content of a Site Master File, ENTR/F2/MT/AM/JR d (2009), 10 December 2009Tue, 30 Mar 2010 11:30:23 GMT2010: PDA Comments on Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Productshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2010-PDA-Comments-on-Planning-for-the-Effects-of-High-Absenteeism-to-Ensure-Availability-of-Medica.aspxPDA is pleased to offer comments on the draft Guidance for Industry, "Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products."Fri, 05 Mar 2010 10:07:51 GMT2010: PDA Comments on Current Good Manufacturing Practice Requirements for Combination Productshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2010-PDA-Comments-on-Current-Good-Manufacturing-Practice-Requirements-for-Combination-Products.aspxPDA is pleased to offer comments on the prposed rule under 21 CFR Part 4, Docket No. FDA-2009-N-0435-0004 in the matter of "Current Good Manufacturing Requirements for Combination Products, f/k/a Docket No. FDA-2008-D-0409. Thu, 18 Feb 2010 09:36:14 GMTPDA Comments on Postmarketing Safety Reporting for Combination Products / FDA-2008-N-0424http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-Postmarketing-Safety-Reporting-for-Combination-Products-FDA-2008-N-0424.aspxPDA is pleased to offer comments on the proposed rule under 21 CFR Part 4, "Postmarketing Safety Reporting for Combination Products."Thu, 04 Feb 2010 13:36:41 GMTPDA Comments on Recommendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Bankshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-Recommendations-for-the-Evaluation-of-Animal-Cell-Cultures-as-Substrates-for-the-Man.aspxN/ATue, 29 Sep 2009 10:23:44 GMTFDA Comments on Federal Docket Management System Docket FDA-2009-D-0179http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/FDA-Comments-on-Federal-Docket-Management-System-Docket-FDA-2009-D-0179.aspxPDA comments on the Draft Guidance for Industry and Food and Drug Administration Staff: Technical Considerations for Pen, Jet, and Related Injectors Intended for Use With Drugs and Biological Products.Wed, 29 Jul 2009 09:34:49 GMT2009: PDA Comments on the Revised TSE Note for Guidancehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2009-PDA-Comments-on-the-Revised-TSE-Note-for-Guidance.aspxPDA comments on the Note for Guidance on Minimising the Risk of Transmitting Animal Spongiform Encephalopathy Agents via Human and Veterinary Medicinal Products (Doc. Ref. EMEA/410/10/01 -- Rev. 4, 21 February 2008Tue, 30 Jun 2009 14:39:16 GMT2009: PDA Comments on Securing the Drug Supply Chainhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2009-PDA-Comments-on-Securing-the-Drug-Supply-Chain.aspxPDA comments on the Draft Guidance for Industry on Standards for Securing the Drug Supply chain -- Standardized Numerical Indentification for Prescription Drug PackagesWed, 15 Apr 2009 15:10:37 GMT2009: PDA Comments to EDQM Pharmaeuropa Chapter XXXX:2031http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2009-PDA-Comments-to-EDQM-Pharmaeuropa-Chapter-XXXX2031.aspxPDA comments to EDQM on Pharmaeuropa Volume 21, No. 1, January 2009, proposed revisions to Chapter XXXX:2031, "Monoclonal Antibodies for Human Use."Mon, 06 Apr 2009 09:24:55 GMT2009: PDA Comments to EDQM on Pharmaeuropa Chapters 2.6.16 and 5.2.3http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2009-PDA-Comments-to-EDQM-on-Pharmaeuropa-Chapters-2616-and-523.aspxPDA comments on Pharmaeuropa Volume 21, No. 1, January 2009 on Proposed Revisions to Chapter 2.6.16, "Test for Extraneous Agents in Biological Products," and Chapter 5.2.3, "Cell Substrates for the Production of Biological Products."Mon, 06 Apr 2009 09:21:10 GMT2009: PDA Comments on the Process Validation Guidancehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2009-PDA-Comments-on-the-Process-Validation-Guidance.aspxPDA's official comments along with verbatim comments made by PDA members on the Draft Guidance for Industry on Process Validation: General Principles and Practices. Verbatim comments submitted by PDA Members have not been approved by the PDA Regulatory Affairs and Quality Committee or the PDA Board of Directors. They do not reflect official PDA comments. They are provided for educational proposes only. Fri, 20 Mar 2009 12:38:49 GMT2009: PDA Comments on EU Guidelines to GMP, Draft Annex 13http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-EU-Guidelines-to-GMP-Medicinal-Products-for-Human-and-Veterinary-Use-Draft-Annex-1.aspxPDA comments on the Draft Guidance EU Guidelines to GMP, Medicinal Products for Human and Veterinary Use, Draft Annex 13, Manufacture of Investigational Medicinal ProductsThu, 29 Jan 2009 10:37:48 GMT2009: PDA Comments on Draft Guidance on Potency Testing of Cellular and Gene Therapy Productshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Commentary-on-Draft-Guidance-on-Potency-Testing-of-Cellular-and-Gene-Therapy-Products-Submitted.aspxPDA comments on Draft Guidance for Industry on Potency Testing of Cellular and Gene Therapy Products Mon, 12 Jan 2009 14:28:45 GMT2008: PDA Comments on Draft Guidance for Parametric Releasehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-Draft-Guidance-for-Parametric-Release.aspxPDA comments on the Draft Guidance for Industry on Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat ProcessesFri, 06 Mar 2009 16:10:46 GMT2008http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2008.aspxN/AFri, 11 Jul 2008 09:36:02 GMT2008: PDA Comments on EU Guidelines to GMP, Draft Annex 11 (Computerised Systems)http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-EU-Guidelines-to-GMP-Draft-Annex-11-Computerised-Systems.aspxPDA comments on the Draft Guidance EU Guidelines to GMP, Medicinal Products for Human and Veterinary Use, Draft Annex 11, Computerized SystemsThu, 15 Jan 2009 10:22:00 GMT2008: PDA Comments on EU Guidelines to GMP Chapter 4http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDA-Comments-on-EU-Guidelines-to-GMP-Chapter-4.aspxPDA comments on the Draft Guidance EU Guidelines to GMP, Medicinal Products for Human and Veterinary UseWed, 14 Jan 2009 09:31:07 GMT2008: PDA Comments on ICH Q8 http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/PDACommentsonICHQ8.aspxPDA comments on the Draft Guidance ICH Q8 Annex, Pharmaceutical DevelopmentMon, 15 Sep 2008 12:34:58 GMT2008: PDA Comments on GMP Draft Annex 2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/annex2pdacvrltrcommenttblfinal.aspxPDA Comments on GMP Draft Annex 2: Manufacture of Biological Medicinal Product for Human UseFri, 11 Jul 2008 09:36:12 GMTRegulatory Affairs and Quality Committee/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryAffairsandQualityCommitteRAQC.aspxN/ASun, 07 Sep 2008 14:38:27 GMT2008: PDA Comments on Proposed Changes to Drug Product GMPs for Finished Pharmaceuticals http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/pdacommentsonproposedchangestogmpscommentgrid.aspxPDA Comments on Proposed Changes to Drug Product GMPs for Finished Pharmaceuticals Fri, 11 Jul 2008 09:36:35 GMT2008: PDA Comments on ICH Draft Guidance on Q4Bhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/draftguidanceq4bannexiiicvrltcommentary.aspxPDA Comments on Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex 3 on Test Particulate Contamination: Subvisible Particles General ChapterFri, 11 Jul 2008 09:36:16 GMTRAQC Info2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/RAQCInfo2.aspxN/AFri, 11 Jul 2008 09:23:43 GMTmay_2_withdrawal_direct_final_rulehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/RAQCInfo2/may2withdrawaldirectfinalrule.aspxN/AFri, 11 Jul 2008 09:37:58 GMTgmp annex 1 submission letter to the emeahttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/RAQCInfo2/gmpannex1submissionlettertotheemea.aspxN/AFri, 11 Jul 2008 09:37:54 GMTannex 1 comment submission document to the emeahttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/RAQCInfo2/annex1commentsubmissiondocumenttotheemea.aspxN/AFri, 11 Jul 2008 09:37:50 GMTPDFshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/RAQCInfo2/PDFs.aspxN/AFri, 11 Jul 2008 09:26:14 GMTmisc docshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/RAQCInfo2/miscdocs.aspxN/AFri, 11 Jul 2008 09:23:45 GMTcommentshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/comments.aspxN/AFri, 11 Jul 2008 09:36:07 GMTRegulatory Comments Archivehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/comments/RegulatoryCommentsArchive.aspxN/AMon, 11 Aug 2008 16:52:58 GMTminutes_raqc_january_2008http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/comments/minutesraqcjanuary2008.aspxN/AFri, 11 Jul 2008 09:36:31 GMT2008_meeting_dateshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/comments/2008meetingdates.aspxN/AFri, 11 Jul 2008 09:36:26 GMTraqc_minutes_february_28_2008http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/comments/raqcminutesfebruary282008.aspxN/AFri, 11 Jul 2008 09:36:50 GMTRegulatory Comments 2007http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/comments/RegulatoryComments2007.aspxN/AMon, 11 Aug 2008 17:32:48 GMT2007 Regulatory Comments Archivehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007.aspxN/AFri, 11 Jul 2008 09:34:35 GMTPDA Comments on Guideline on Production and Quality Control of Monoclonal Antibodies and Related Substanceshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/pdacvrltrtableemeamabfinal29nov07.aspxN/AFri, 11 Jul 2008 09:43:14 GMTPDA Comments on ICHQ10 Pharmaceutical Quality Systemshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/ichq10coverletter100907.aspxCover Letter to the FDA, October 9, 2007Fri, 11 Jul 2008 09:35:06 GMTPDA Comments on ICH10: Pharmaceutical Quality System Comment Table, October 2007 http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/ichq10commentgridfinal2.aspxN/AFri, 11 Jul 2008 09:35:11 GMTPDA Comments on Revisions to Canadian GMPs1http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/cvrltrproposedchangescanadiangmpregs.aspxProposal Letter to HPFD from PDAFri, 11 Jul 2008 09:34:52 GMTPDA Comments on Revisions to Canadian GMPs2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/draftcommentstohealthcanada21907.aspxPDA Recommendation and Rational Regarding the Proposal for Revisions to Canadian GMPs Fri, 11 Jul 2008 09:34:56 GMTPDA comments on the EMEA's draft content of the Batch Release certificate referred to in Art. 13.3 of Directive 2001/20/EC http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/pdacommentsimpbatchreleasecertificate.aspxN/AFri, 11 Jul 2008 09:35:26 GMTPDA Comments on the Proposed Revision to Chapter 1 of the GMP Guide to Include Reference to Quality Risk Management (QRM) Principles http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/finalpdalettercommentschapter1.aspxN/AFri, 11 Jul 2008 09:35:01 GMTPDA Comments on the Proposed Revision to Chapter 1 of the GMP Guide to Include Reference to Quality Risk Management (QRM) Principles http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2007/Final_PDA_LetterComments_Chapter_1.aspxFinal_PDA_LetterComments_Chapter_1.pdfSat, 20 Sep 2008 10:56:00 GMT2006 Regulatory Comments Archiveshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006.aspxN/AFri, 11 Jul 2008 09:33:09 GMTAnnex 1 Comment Submission Document to the EMEA http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/2007annex1commentsubmissiondocumenttotheemea.aspxN/AThu, 10 Jul 2008 11:23:10 GMTPDA Comments on Virus Safety Evaluation of Biotechnological Investigational Medicinal Products Guidance2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/emeachmpbwpgrid1307.aspxSubmission Comments on Safety Evaluation of Biotechnological Investigational Medicinal Products Guidance Thu, 10 Jul 2008 13:07:33 GMTPDA Comments on Biological Starting Materials Guidance1http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/cellsubtratesletter1307.aspxCover Letter to the U.S. FDA, Dec. 21, 2006 Thu, 10 Jul 2008 13:07:30 GMTPDA Comments on Biological Starting Materials Guidance2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/cellsubrtratesgrid1307.aspxSubmission Comments on Biological Starting Materials GuidanceThu, 10 Jul 2008 13:07:27 GMTDirect Final and Proposed Rules: Current Good Manufacturing Practice Regulation and Investigational New Drugshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/fdacoverletterdirectandfinalrule04032006.aspxN/AFri, 11 Jul 2008 09:33:41 GMTPDA Comments on Virus Safety Evaluation of Biotechnological Investigational Medicinal Products Guidance1http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/vsbiotechimpsletter1307.aspxCover Letter to the EMEA, Dec. 28, 2006Thu, 10 Jul 2008 13:07:42 GMTPDA Comments on GMP Annex 11http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/annex1.aspxCover Letter to the EMEA, April 24, 2006 Thu, 10 Jul 2008 13:29:47 GMTPDA Comments on GMP Annex 12http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/200605submissioncommentsannex1summaryapril242006.aspxPDA Comments on EMEA's Annex 1Thu, 10 Jul 2008 13:28:33 GMTPDA Comments on GMP Annex 14http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/200605annex1pdaversionfinal.aspxPDA Suggested Text for Annex 1 Thu, 10 Jul 2008 13:28:27 GMTDraft Guidance for Industry: INDs - Approaches to Complying with CGMP During Phase I, Docket No. 2005D-0286 http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/2006cvrletterdraftguidanceindsmarch172006.aspxN/AThu, 10 Jul 2008 13:28:45 GMTPDA Comments on Draft FDA Guidance for Industry - Phase I GMPs http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/draftcommentgridraqcapprovalforphase1gmpguidance.aspxExcel SpreadsheetFri, 11 Jul 2008 09:24:01 GMT2006 FDA Cover Letter Direct and Final Rulehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2006/2006fdacoverletterdirectandfinalrule04032006.aspxN/AThu, 10 Jul 2008 13:28:48 GMT2005 Regulatory Comments Archivehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2005.aspxN/AFri, 11 Jul 2008 09:29:06 GMTPDA Comments on the Proposed Changes to USP General Chapter 1 Injectionshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2005/2005uspproposalbodapproval123005.aspxN/AThu, 10 Jul 2008 13:07:24 GMTPDA Comments on ICH Q91http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2005/midwestchptcommentsichq9cvrltr.aspxCover LetterThu, 10 Jul 2008 13:07:36 GMTPDA Comments on ICH Q92http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2005/submissionfinalpdacommentsichq9083105.aspxFinal Comments Grid (Excel Spreadsheet)Thu, 10 Jul 2008 13:07:39 GMTICH Q8http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2005/2005docket2005d0021dup.aspxDocket No. 2005D-0021Thu, 10 Jul 2008 13:07:21 GMT2004http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004.aspxN/AFri, 11 Jul 2008 09:26:24 GMTwho agenda pharmaceutical committee_ mtg october 2004http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/whoagendapharmaceuticalcommitteemtgoctober2004.aspxN/AFri, 11 Jul 2008 09:29:02 GMTviral safety evaluation of biotech products to be used in clin trialshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/viralsafetyevaluationofbiotechproductstobeusedinclintrials.aspxN/AFri, 11 Jul 2008 09:28:59 GMTusp human tissue monographshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/usphumantissuemonographs.aspxN/AFri, 11 Jul 2008 09:28:54 GMTraqcminutes_12nov04http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/raqcminutes12nov04.aspxN/AFri, 11 Jul 2008 09:28:51 GMTraqc work flow documenthttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/raqcworkflowdocument.aspxN/AFri, 11 Jul 2008 09:28:48 GMTraqc comment time october 2004 finalhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/raqccommenttimeoctober2004final.aspxN/AFri, 11 Jul 2008 09:28:44 GMTraqc mission roles october 2004 finalhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/raqcmissionrolesoctober2004final.aspxN/AFri, 11 Jul 2008 09:28:41 GMTpresident bush healthpolicyhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/presidentbushhealthpolicy.aspxN/AFri, 11 Jul 2008 09:28:37 GMTpics qshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/picsqs.aspxN/AFri, 11 Jul 2008 09:28:34 GMTich s8 step 2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/ichs8step2.aspxN/AFri, 11 Jul 2008 09:28:30 GMTich q9http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/ichq9.aspxN/AFri, 11 Jul 2008 09:28:26 GMTich q9 draft 3 102804http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/ichq9draft3102804.aspxN/AFri, 11 Jul 2008 09:28:21 GMTich q8 version 3 - 10 june 2004http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/ichq8version310june2004.aspxN/AFri, 11 Jul 2008 09:28:17 GMTich q8 pharmaceutical development step 2http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/ichq8pharmaceuticaldevelopmentstep2.aspxN/AFri, 11 Jul 2008 09:28:14 GMTgmp oversight will have fda-wide coordination under rx quality councilhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/gmpoversightwillhavefdawidecoordinationunderrxqualitycouncil.aspxN/AFri, 11 Jul 2008 09:28:10 GMTgerman biotech inspectionhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/germanbiotechinspection.aspxN/AFri, 11 Jul 2008 09:28:07 GMTfinal raqc document management process october 2004 finalhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/finalraqcdocumentmanagementprocessoctober2004final.aspxN/AFri, 11 Jul 2008 09:28:03 GMTfda vaccine labelhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdavaccinelabel.aspxN/AFri, 11 Jul 2008 09:28:00 GMTfda supplement claimshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdasupplementclaims.aspxN/AFri, 11 Jul 2008 09:27:56 GMTfda quality systems guidance suggests trending for batch testinghttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdaqualitysystemsguidancesuggeststrendingforbatchtesting.aspxN/AFri, 11 Jul 2008 09:27:53 GMTfda improves the safety of human cells and tissues by finalizing new rules for _good tissue practice_http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdaimprovesthesafetyofhumancellsandtissuesbyfinalizingnewrulesforgoodtissuepractice.aspxN/AFri, 11 Jul 2008 09:27:50 GMTfda guidance on consultants and biotech clinicalshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdaguidanceonconsultantsandbiotechclinicals.aspxN/AFri, 11 Jul 2008 09:27:47 GMTfda feecomboprodshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdafeecomboprods.aspxN/AFri, 11 Jul 2008 09:27:43 GMTfda dispute resolution mapphttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdadisputeresolutionmapp.aspxN/AFri, 11 Jul 2008 09:27:40 GMTfda dietary supplementshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdadietarysupplements.aspxN/AFri, 11 Jul 2008 09:27:37 GMTfda dietary sup guidancehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdadietarysupguidance.aspxN/AFri, 11 Jul 2008 09:27:33 GMTfda creates four new drug chemistry divisions for cmc evaluationhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdacreatesfournewdrugchemistrydivisionsforcmcevaluation.aspxN/AFri, 11 Jul 2008 09:27:30 GMTfda cmc review gene therapyhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/fdacmcreviewgenetherapy.aspxN/AFri, 11 Jul 2008 09:27:26 GMTeu proposed annex 19 gmpshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/euproposedannex19gmps.aspxN/AFri, 11 Jul 2008 09:27:23 GMTeu paediatrichttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/eupaediatric.aspxN/AFri, 11 Jul 2008 09:27:20 GMTeu paediatric proposalhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/eupaediatricproposal.aspxN/AFri, 11 Jul 2008 09:27:16 GMTeu paediatric press releasehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/eupaediatricpressrelease.aspxN/AFri, 11 Jul 2008 09:27:13 GMTeu innovation report nov 04http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/euinnovationreportnov04.aspxN/AFri, 11 Jul 2008 09:27:10 GMTeu impdhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/euimpd.aspxN/AFri, 11 Jul 2008 09:27:06 GMTeu annex 19 gmp proposalhttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/euannex19gmpproposal.aspxN/AFri, 11 Jul 2008 09:27:03 GMTemea press release doc procedurehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeapressreleasedocprocedure.aspxN/AFri, 11 Jul 2008 09:27:00 GMTemea inspection info exchange procedureshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeainspectioninfoexchangeprocedures.aspxN/AFri, 11 Jul 2008 09:26:56 GMTemea guidance procedurehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeaguidanceprocedure.aspxN/AFri, 11 Jul 2008 09:26:53 GMTemea gmp inspections 3rd countrieshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeagmpinspections3rdcountries.aspxN/AFri, 11 Jul 2008 09:26:49 GMTemea gmp inspection procedurehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeagmpinspectionprocedure.aspxN/AFri, 11 Jul 2008 09:26:46 GMTemea glp inspection sophttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeaglpinspectionsop.aspxN/AFri, 11 Jul 2008 09:26:43 GMTemea fees payable to emeahttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeafeespayabletoemea.aspxN/AFri, 11 Jul 2008 09:26:39 GMTemea edi guidancehttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeaediguidance.aspxN/AFri, 11 Jul 2008 09:26:36 GMTemea document procedureshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeadocumentprocedures.aspxN/AFri, 11 Jul 2008 09:26:33 GMTemea consultation procedureshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeaconsultationprocedures.aspxN/AFri, 11 Jul 2008 09:26:29 GMTemea concept monoclonal antibodieshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2004/emeaconceptmonoclonalantibodies.aspxN/AFri, 11 Jul 2008 09:26:26 GMT2003http://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2003.aspxN/AFri, 11 Jul 2008 09:26:17 GMTarticle cgmps in the production of clinical supplieshttp://www.pda.org/MainMenuCategory/QualityRegulatoryAffairs/RegulatoryComments/2003/articlecgmpsintheproductionofclinicalsupplies.aspxN/AFri, 11 Jul 2008 09:26:20 GMT